Medical News

Monoclonal antibody prevents malaria in adults

Heather Mason   |   23 November 2022

A single administration of the monoclonal antibody CIS43LS at 40 mg was 88.2% effective in preventing infection by Plasmodium falciparum , the mosquito-transmitted parasite that causes malaria.

The two-part phase two clinical trial enrolled 369 participants in Mali aged 18 to 55 years. In part A, 18 participants received CIS43LS...


Topic Challenges